A detailed history of Merriman Wealth Management, LLC transactions in Chroma Dex Corp. stock. As of the latest transaction made, Merriman Wealth Management, LLC holds 11,800 shares of CDXC stock, worth $88,028. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,800
Previous 11,800 -0.0%
Holding current value
$88,028
Previous $32,000 34.38%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$2.44 - $4.32 $28,792 - $50,976
11,800 New
11,800 $32,000
Q1 2022

Apr 28, 2022

BUY
$2.02 - $3.92 $23,836 - $46,256
11,800 New
11,800 $29,000

Others Institutions Holding CDXC

About ChromaDex Corp.


  • Ticker CDXC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,350,896
  • Market Cap $510M
  • Description
  • ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...
More about CDXC
Track This Portfolio

Track Merriman Wealth Management, LLC Portfolio

Follow Merriman Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Merriman Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Merriman Wealth Management, LLC with notifications on news.